Chronic disease prevalence in women and air pollution--A 30-year longitudinal cohort study.

BACKGROUND Air pollution, such as fine particulate matter (PM2.5), can increase risk of adverse health events among people with heart disease, diabetes, asthma and chronic obstructive pulmonary disease (COPD) by aggravating these conditions. Identifying the influence of PM2.5 on prevalence of these conditions may help target interventions to reduce disease morbidity among high-risk populations. OBJECTIVES The objective of this study is to measure the association of exposure of PM2.5 with prevalence risk of various chronic diseases among a longitudinal cohort of women. METHODS Women from Ontario who enrolled in the Canadian National Breast Screening Study (CNBSS) from 1980 to 1985 (n = 29,549) were linked to provincial health administrative data from April 1, 1992 to March 31, 2013 to determine the prevalence of major chronic disease and conditions (heart disease, diabetes, asthma, COPD, acute myocardial infarction, angina, stroke and cancers). Exposure to PM2.5 was measured using satellite data collected from January 1, 1998 to December 31, 2006 and assigned to resident postal-code at time of entry into study. Poisson regression models were used to describe the relationship between exposure to ambient PM2.5 and chronic disease prevalence. Prevalence rate ratios (PRs) were estimated while adjusting for potential confounders: baseline age, smoking, BMI, marital status, education and occupation. Separate models were run for each chronic disease and condition. RESULTS Congestive heart failure (PR = 1.31, 95% CI: 1.13, 1.51), diabetes (PR = 1.28, 95% CI: 1.16, 1.41), ischemic heart disease (PR = 1.22, 95% CI: 1.14, 1.30), and stroke (PR = 1.21, 95% CI: 1.09, 1.35) showed over a 20% increase in PRs per 10 μg/m(3) increase in PM2.5 after adjusting for risk factors. Risks were elevated in smokers and those with BMI greater than 30. CONCLUSIONS This study estimated significant elevated prevalent rate ratios per unit increase in PM2.5 in nine of the ten chronic diseases studied.

[1]  S. Barr,et al.  Changes in body mass index in Canadians over a five-year period: Results of a prospective, population-based study , 2007, BMC public health.

[2]  Paul J. Villeneuve,et al.  Risk of Incident Diabetes in Relation to Long-term Exposure to Fine Particulate Matter in Ontario, Canada , 2013, Environmental health perspectives.

[3]  A. Miller,et al.  Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years. , 1992, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[4]  R. Burnett,et al.  Spatial Association Between Ambient Fine Particulate Matter and Incident Hypertension , 2014, Circulation.

[5]  D. Consonni,et al.  Estimation of prevalence rate ratios from cross-sectional data. , 1995, International journal of epidemiology.

[6]  R. Burnett,et al.  Air Pollution and Incidence of Hypertension and Diabetes Mellitus in Black Women Living in Los Angeles , 2012, Circulation.

[7]  Thomas Kuhlbusch,et al.  Association of ambient air pollution with the prevalence and incidence of COPD , 2014, European Respiratory Journal.

[8]  J. Schwartz,et al.  Are Particulate Matter Exposures Associated with Risk of Type 2 Diabetes? , 2010, Environmental health perspectives.

[9]  J. Samet,et al.  Air Pollution and Cardiovascular Disease: A Statement for Healthcare Professionals From the Expert Panel on Population and Prevention Science of the American Heart Association , 2004, Circulation.

[10]  I. Vejborg,et al.  Overdiagnosis in screening mammography in Denmark: population based cohort study , 2013, BMJ : British Medical Journal.

[11]  Yuval,et al.  Cumulative exposure to particulate matter air pollution and long-term post-myocardial infarction outcomes. , 2013, Preventive medicine.

[12]  R. Royall.  Model robust confidence intervals using maximum likelihood estimators , 1986 .

[13]  A. Miller,et al.  Canadian National Breast Screening Study. , 1990, AJR. American journal of roentgenology.

[14]  Teresa To,et al.  The Air Quality Health Index and Asthma Morbidity: A Population-Based Study , 2012, Environmental health perspectives.

[15]  John S. Brownstein,et al.  Association Between Fine Particulate Matter and Diabetes Prevalence in the U.S. , 2010, Diabetes Care.

[16]  A. Anttila,et al.  Overdiagnosis due to breast cancer screening: updated estimates of the Helsinki service study in Finland , 2014, British Journal of Cancer.

[17]  J. Parker,et al.  Air pollution exposure and self-reported cardiovascular disease. , 2009, Environmental research.

[18]  G. Zou,et al.  A modified poisson regression approach to prospective studies with binary data. , 2004, American journal of epidemiology.

[19]  Wolfgang Rathmann,et al.  Traffic-Related Air Pollution and Incident Type 2 Diabetes: Results from the SALIA Cohort Study , 2010, Environmental health perspectives.

[20]  Sabit Cakmak,et al.  Long-Term Fine Particulate Matter Exposure and Mortality From Diabetes in Canada , 2013, Diabetes Care.

[21]  Ikenna C. Eze,et al.  Long-term air pollution exposure and diabetes in a population-based Swiss cohort. , 2014, Environment international.

[22]  M. Brauer,et al.  Global Estimates of Ambient Fine Particulate Matter Concentrations from Satellite-Based Aerosol Optical Depth: Development and Application , 2010, Environmental health perspectives.

[23]  M. Brauer,et al.  Risk of Nonaccidental and Cardiovascular Mortality in Relation to Long-term Exposure to Low Concentrations of Fine Particulate Matter: A Canadian National-Level Cohort Study , 2012, Environmental health perspectives.